Literature DB >> 8837929

Implication of the endogenous opioid system in excessive ethanol consumption.

C Gianoulakis1, J P de Waele, J Thavundayil.   

Abstract

Numerous human and animal studies suggest that certain genetic factors may increase an individual's vulnerability to excessive alcohol consumption. Human and animal studies suggest that some of the reinforcing effects of ethanol may be mediated by the endogenous opioid system. In human studies, plasma levels of subjects genetically at high risk for excessive alcohol consumption showed lower basal activity of beta-endorphin, and more pronounced release of beta-endorphin in response to ethanol. In animal studies, the hypothalamus of mice bred for ethanol preference showed high basal activity of beta-endorphin and more pronounced release of beta-endorphin in response to ethanol than control mice. An important factor in the development of excessive ethanol consumption is the increase in opioidergic activity shortly after individuals begin drinking ethanol. Increased opioidergic activity could mediate the rewarding effects of ethanol, reinforce the act of drinking, and increase ethanol consumption. Human and animal studies, in which the administration of the opioid antagonists naloxone and naltrexone decreased ethanol consumption both by ethanol-preferring animals and by recovering alcoholics, support this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8837929     DOI: 10.1016/0741-8329(95)02035-7

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  22 in total

Review 1.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

2.  Endogenous opioids as substrates for ethanol intake in the neonatal rat: The impact of prenatal ethanol exposure on the opioid family in the early postnatal period.

Authors:  Kelly Bordner; Terrence Deak
Journal:  Physiol Behav       Date:  2015-02-07

3.  Beta-endorphin mediates behavioral despair and the effect of ethanol on the tail suspension test in mice.

Authors:  Elizabeth T Barfield; Sarah M Barry; Hali B Hodgin; Brittany M Thompson; Stephani S Allen; Judith E Grisel
Journal:  Alcohol Clin Exp Res       Date:  2010-04-09       Impact factor: 3.455

4.  β-Endorphin neuronal transplantation into the hypothalamus alters anxiety-like behaviors in prenatal alcohol-exposed rats and alcohol-non-preferring and alcohol-preferring rats.

Authors:  Ryan W Logan; Olivia Wynne; George Maglakelidze; Changqing Zhang; Stephanie O'Connell; Nadka I Boyadjieva; Dipak K Sarkar
Journal:  Alcohol Clin Exp Res       Date:  2015-01       Impact factor: 3.455

5.  Persistent Changes in Stress-Regulatory Genes in Pregnant Women or Children Exposed Prenatally to Alcohol.

Authors:  Dipak K Sarkar; Omkaram Gangisetty; Jeffrey R Wozniak; Judith K Eckerle; Michael K Georgieff; Tatiana M Foroud; Leah Wetherill; Wladimir Wertelecki; Christina D Chambers; Edward Riley; Natalya Zymak-Zakutnya; Lyubov Yevtushok
Journal:  Alcohol Clin Exp Res       Date:  2019-08-06       Impact factor: 3.455

6.  Exploring Sex Differences in the Attenuation of Ethanol Drinking by Naltrexone in Dependent Rats During Early and Protracted Abstinence.

Authors:  Alessandra Matzeu; Lars Terenius; Remi Martin-Fardon
Journal:  Alcohol Clin Exp Res       Date:  2018-10-28       Impact factor: 3.455

7.  Ethanol has concentration-dependent effects on hypothalamic POMC neuronal excitability.

Authors:  Jonna M Leyrer-Jackson; Erin K Nagy; Lauren E Hood; Jason M Newbern; Cassandra D Gipson; M Foster Olive
Journal:  Alcohol       Date:  2020-04-15       Impact factor: 2.405

8.  A Novel and Selective Nociceptin Receptor (NOP) Agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) Decreases Acquisition of Ethanol-Induced Conditioned Place Preference in Mice.

Authors:  Nurulain T Zaveri; Paul V Marquez; Michael E Meyer; Willma E Polgar; Abdul Hamid; Kabirullah Lutfy
Journal:  Alcohol Clin Exp Res       Date:  2018-01-19       Impact factor: 3.455

Review 9.  Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.

Authors:  Bankole A Johnson
Journal:  Biochem Pharmacol       Date:  2007-08-09       Impact factor: 5.858

10.  Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals.

Authors:  Dennis D Rasmussen; Carrie L Kincaid; Janice C Froehlich
Journal:  Alcohol Clin Exp Res       Date:  2015-08-11       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.